Dear Colleague:

I am pleased to provide you with the preliminary agenda for the Pharmaceutical
Strategy Series’ Second Annual Global R&D Congress: The Premier Event for
Discovery and Development Operations in Emerging Regions. This event brings
together the experts and delegates from our industry-recognized annual China and
India conferences, as well as those involved in projects in Greater Asia, Russia, and
Latin America.

The 2008 Global R&D Congress will be a two-day interactive forum of in-depth case
studies, roundtable and panel discussions, keynote presentations, and break-out
sessions by function area. The focus will be on specific strategies and approaches
to navigating the opportunities and challenges of drug discovery and development
in emerging regions.

Key Take Aways:

• UNDERSTAND IP barriers and trends when planning a global strategy in India,
  China and other markets

• IMPLEMENT best approaches to outsourcing, in-licensing, out-licensing and risk
  sharing partnerships

• EXAMINE the regulatory landscape of Asia, Eastern Europe and Latin America

• CLARIFY the business, regulatory and research environment for drug discovery,
  drug development and clinical research

• MANAGE complicated and long-distance collaborative third-party relationships

• OVERCOME the logistical challenges of transferring technology, data, and staff

• FIND the best discovery and development services and partners

Please review our agenda, and I think you’ll agree this is one event not to miss!
I hope to see you on May 29-30, 2008 at the Ritz-Carlton in Washington, DC.

Sincerely,

Conference Director
Pharmaceutical Strategy Series, a division of Cambridge Healthtech Institute